A Randomized Controlled Trial of the Tumor Necrosis Factor-alpha Antagonist Infliximab in Treatment Resistant Depression: Role of Baseline Inflammatory Biomarkers

CONTEXT: Increased inflammatory biomarkers predict antidepressant non-response, and inflammatory cytokines can sabotage and circumvent mechanisms of action of conventional antidepressant therapy. OBJECTIVE: To determine whether inhibition of the inflammatory cytokine tumor necrosis factor (TNF)-alph...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Raison, Charles L., Rutherford, Robin E., Woolwine, Bobbi J., Shuo, Chen, Schettler, Pamela, Drake, Daniel F., Haroon, Ebrahim, Miller, Andrew H.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015348/
https://ncbi.nlm.nih.gov/pubmed/22945416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/2013.jamapsychiatry.4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars